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ABSTRACT
Homologous recombination functions universally in
the maintenance of genome stability through
the repair of DNA breaks and in ensuring the
completion of replication. In some organisms,
homologous recombination can perform more spe-
cific functions. One example of this is in antigenic
variation, a widely conserved mechanism for the
evasion of host immunity. Trypanosoma brucei, the
causative agent of sleeping sickness in Africa,
undergoes antigenic variation by periodic changes
in its variant surface glycoprotein (VSG) coat. VSG
switches involve the activation of VSG genes, from
an enormous silent archive, by recombination into
specialized expression sites. These reactions
involve homologous recombination, though they
are characterized by an unusually high rate of
switching and by atypical substrate requirements.
Here, we have examined the substrate parameters
of T. brucei homologous recombination. We show,
first, that the reaction is strictly dependent on
substrate length and that it is impeded by base
mismatches, features shared by homologous
recombination in all organisms characterized.
Second, we identify a pathway of homologous
recombination that acts preferentially on short
substrates and is impeded to a lesser extent
by base mismatches and the mismatch repair
machinery. Finally, we show that mismatches
during T. brucei recombination may be repaired by
short-patch mismatch repair.
INTRODUCTION
Homologous recombination is a universal process in living
organisms. The central enzyme of this reaction appears to
have been conserved in all kingdoms of life (1) and in
viruses: RecA in bacteria, Rad51 in eukaryotes, RadA in
archaea and UvsX in phageT4 (2). In each case, the
enzyme functions by catalysing the exchange of single-
stranded DNA into intact DNA duplex, generating
homologous pairing and promoting recombination (3).
Furthermore, each orthologous protein binds single-
stranded DNA in the form of a nucleoprotein ﬁlament,
which has a highly similar structure in Escherichia coli (4),
Saccharomyces cerevisiae (5) and Archeoglobus fulgidus
(6). The purpose of homologous recombination is to
repair DNA double-strand breaks (3) and to restart stalled
or collapsed replication forks (7). In eukaryotes, it is also
used in meiotic recombination (8) and, in some circum-
stances, telomere maintenance (9). Beyond these general-
ized functions, homologous recombination has been co-
opted into speciﬁc functions in a diverse set of organisms.
One example is mating type switching in yeast, where
homologous recombination is induced by site-directed
DNA lesions (10). In many pathogenic organisms,
including bacteria, fungi and protists, homologous
recombination can play a similarly specialized role in
host immune evasion (11–13).
One way pathogens evade immunity is by antigenic
variation, the periodic switching of surface antigens.
In Trypanosoma brucei, a protistan parasite of mammals
in Africa, antigenic variation involves switches in the
variant surface glycoprotein (VSG) coat. The success of
this strategy relies upon a T. brucei cell expressing a single
VSG coat type at any one time, and the ability to switch
to an antigenically distinct version, selected from an
enormous archive of 41000 silent VSG genes (14); for
recent reviews see (15–19). Singular VSG expression has
involved the evolution of telomeric VSG transcription
units, termed expression sites (ES), and transcriptional
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dependent on recombination of the silent VSGs into the
ES, and a number of such reactions have been described.
The most commonly observed, at least early in T. brucei
infections, are gene conversions that generate a copy of a
silent VSG and transfer it to the ES. Such gene
conversions encompass the VSG ORF and extend to
regions of homology upstream and downstream.
VSG-associated 70-bp repeats frequently demarcate the
upstream conversion boundary (20,21), whilst the reaction
can extend downstream to short blocks of homology in
the VSG 30 ends (22) or to the telomeric repeats (23).
Crossover exchanges between chromosome ends, termed
reciprocal VSG switches, are also seen (24). Finally,
segmental gene conversions are found where multiple VSG
pseudogenes are recombined together to form novel,
mosaic VSGs (25,26). These have been considered rare
events, found late in infections. However, sequencing the
T. brucei genome has revealed that VSG pseudogenes
represent the substantial majority of the VSG archive (14),
arguing that this is likely to be a signiﬁcant mechanism of
VSG switching (26,27).
Growing evidence suggests that VSG switching is
closely linked to homologous recombination, since muta-
tions in several key factors of homology-directed strand
exchange, including RAD51 (28), a RAD51-related
protein called RAD51-3 (29) and BRCA2 (C.Hartley
and R.McCulloch, unpublished data), impair the immune
evasion process. However, T. brucei VSG switching
presents several unusual characteristics. First, the reaction
can occur at very high rates (up to 1 10
 2 switches/cell/
generation)(30,31), signiﬁcantly more frequent than the
rates of general homologous recombination, which are
more typical of random mutation (32). Second, recombi-
nation of VSGs frequently relies on ﬂanking sequences,
such as the 70bp repeats, that are rather short and share
limited homology (33,34), despite the fact that the
T. brucei mismatch repair (MMR) machinery regulates
homologous recombination to favour well-matched
sequences, and estimates suggest that around 100bp of
homology are needed for eﬃcient RAD51-mediated
recombination (35). Finally, there appears to be a
hierarchy in the substrates that are used by general
homologous recombination in other organisms: sister
chromatids appear to be the favoured substrate in both
yeast (36) and mammals (32), while allelic sequences on
chromosome homologues and homologous sequences at
ectopic locations are progressively disfavoured (37,38).
Recombinational activation of allelic VSG sequence on
the sister chromatid would not result in a coat switch,
compelling the reaction to search for silent VSGs
throughout the genome. It has been argued that this is
why the VSG archive is predominantly sub-telomeric, as
these locations appear to escape such substrate constraints
(39). Beyond that, it is unclear how the other character-
istics of VSG switching are accommodated by homo-
logous recombination. One study has suggested that the
T. brucei homologous recombination is distinct from that
of S. cerevisiae and its relatively close cousin Leishmania,
in that the reaction can act on short stretches of homology
and may have an elevated rate of strand exchange (40),
perhaps indicating modiﬁcations of the recombination
machinery. Another study has suggested that it may be
necessary for T. brucei to suppress MMR to allow
homologous recombination to act during VSG switching
(33). Here, we have sought to examine the parameters of
homologous recombination in T. brucei in order to
address these questions further. To do this we have used
a transformation assay that allows us to measure the
eﬃciency of T. brucei recombination, and to assess the
pathways that operate.
In previous work, we characterized the T. brucei MMR
machinery (41), which plays a critical role in maintaining
genome stability and is conserved throughout evolution.
The function of MMR is to recognize and excise base
mismatches, which arise through replication errors, by
chemical damage or during recombination between
incompletely sequence-matched DNA molecules (42,43).
Eukaryotic MMR is catalysed by homologues of bacterial
MutS and MutL proteins, though the machinery has
been elaborated, since most eukaryotes encode 3-7 MutS-
related proteins (termed MSH 1-7) and 2-4 MutL-related
proteins (MLH1-3 and PMS1-2). Mutation of either
MSH2 or MLH1 in T. brucei demonstrates that MMR
functions in correcting errors in the nuclear genome (41).
Furthermore, MSH2, and by implication MMR, plays a
role in constraining T. brucei homologous recombination
to occur between well-matched sequences (35). A similar
anti-recombination role for MMR has long been appre-
ciated in other organisms, where it contributes to the
suppression of excessive genome rearrangements and to
speciation (44), though how it occurs remains to be
determined fully. In this work, we extend the above
analysis to show that T. brucei homologous recombination
is strictly dependent on substrate length, in keeping with
ﬁndings in other organisms. In addition, by comparing
the recombination of diverged substrates of diﬀerent
lengths in wild-type cells and in MSH2 mutants, we
have identiﬁed an MMR-independent homologous recom-
bination pathway and ﬁnd that a short-patch MMR
pathway can correct base mismatches during T. brucei
recombination.
MATERIALS AND METHODS
T. bruceistrains, growth andtransformation
Trypanosoma brucei bloodstream form cells were used and
grown at 378C in HMI-9 medium (45). The cells were of
strain HTUB (35), which was derived from the MITat1.2
cell line by insertion of the hygromycin phosphotransfer-
ase (HYG) ORF into the tubulin array; MSH2 hetero-
zygous (þ/ ) and homozygous ( / ) mutants in this
strain have been described before (35). Transformations to
assay recombination eﬃciency were carried out by
electroporation with 3mg of DNA that had been PCR-
ampliﬁed using Herculase (Stratagene) high-ﬁdelity DNA
polymerase (see below). Electroporation conditions were a
single pulse at 1.4kV, 25mF using a Bio-Rad Gene Pulser
II, and at least three transformations were performed
for most constructs. For the transformations, T. brucei
cells were grown maximally to 3 10
6cells ml
 1,
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6cells ml
 1, harvested by cen-
trifugation at 600g for 10min at room temperature, and
then re-suspended in Zimmerman post-fusion medium
supplemented with 1% D-Glucose (46) to a concentration
of 5 10
7cells ml
 1. A total of 2.5 10
7cells were used
per transformation and were allowed to recover following
electroporation by growth in 10ml of non-selective
medium for 18h before antibiotic selection. For this, the
cells were harvested as before and then resuspended in
HMI-9 containing 2.5mg.ml
 1 phleomycin (Cayla) and
spread in 1.0ml aliquots over a 24-well dish. Between 2
and 10 10
6cells were plated out in this way, depending
on the construct being used (see Supplementary Figure 1).
Transformation rates were measured by the number of
wells containing phleomycin-resistant cells after 8–14 days
growth. We have assumed that the cell population in each
well is clonal, arising from a single transformant, though
this underestimates the true number of transformants.
However, calculating the likely correct number of
transformants in each plate using the number of negative
wells, and assuming a Poisson distribution of clones (40),
does not alter the nature of the relationship between
transformation rate and substrate length or homology
(data not shown). In addition, such analysis does not alter
signiﬁcantly the calculated minimum eﬃcient processing
segment, which was determined as described by Shen and
Huang (1986).
Generation ofHYG targeting constructs
For each transformation construct, 24 PCRs were
performed, the products pooled and puriﬁed using a
Qiagen PCR puriﬁcation kit according to manufacturer’s
instructions; 1 QIAquick column was used per six PCRs,
and the pooled PCR products resuspended in distilled
H2O. Each of the diﬀerent sized PCR products
were PCR-ampliﬁed either from pHYGwt::BLE,
pHYG05::BLE or pHYG11::BLE (35), generating con-
structs with 0, 5 or 11% base mismatches relative to the
HTUB (HYGwt) sequence. The oligonucleotide primers
used to generate each construct were size-puriﬁed prior
to the PCR and are named in Supplementary Figure 1
(sequences can be provided on request); the precise length
of each targeting ﬂank in the diﬀerent PCR products, as
well as the number of mismatched bases relative to
HYGwt, is also detailed. For reasons that are unclear, a
125bp construct with 11% sequence divergence could not
be PCR-ampliﬁed and was omitted from the study. All the
puriﬁed PCR products were examined by agarose gel
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Figure 1. Assaying the length and sequence homology requirements of T. brucei recombination. (A) HYG (black box), encoding hygromycin
resistance, was integrated into the tubulin array of bloodstream stage T. brucei cells, replacing an a-tubulin ORF (white box). HYG-transformed cells
were then transformed with constructs containing a bleomycin resistance gene (BLE; dark grey box) and recombination ﬂanks which target
integration to HYG.( B) The HYG recombination ﬂanks of the diﬀerent constructs used in this study are diagrammed. In each, the 50 and 30 ﬂanks
are shown as boxes of decreasing size, depicting the diﬀerent lengths (indicated) of the homology with HYG. The constructs were of three classes: the
ﬂanks had 100% sequence homology with HYG (indicated as 0% divergence), or had base mismatches (depicted by vertical lines) that reduced the
homology to 95% (5% divergence) or 89% (11% divergence).
3480 Nucleic Acids Research, 2007, Vol. 35, No. 10electrophoresis to ensure the lack of visible contaminating
DNA molecules, and their concentration was determined
spectrophotometrically.
Analysis oftransformants
The hygromycin sensitivity or resistance of the T. brucei
cells was determined by replica passaging 100ml of the
phleomycin-resistant transformants into 1.5ml of either
non-selective HMI-9, or media containing 5mg.ml
 1
hygromycin (Roche). Growth was assessed microscopi-
cally 48h later. For Southern analysis of the transfor-
mants, a 15ml culture was grown to a density of
 4 10
6cells ml
 1, harvested by centrifugation as
before, resuspended in 500ml of 1mM EDTA, 100mM
NaCl, 50mM Tris-HCl pH 8.0 and lysed overnight at
378C following the addition of SDS to 1% and proteinase
K to 100mg.ml
 1. DNA was recovered by phenol/chloro-
form extraction and ethanol precipitation, and then
resuspended in distilled H2O. The genomic DNA samples
were digested by restriction enzymes as described by the
manufacturers and separated by electrophoresis, typically
at  30V overnight, on 0.8% agarose gels (Seakem LE
agarose, BioWhittaker Molecular Applications) made
with 1  TAE buﬀer (40mM Tris, 19mM acetic acid,
1mM EDTA) containing 0.2mg.ml
 1 ethidium bromide
(Sigma). DNA was blotted by capillary transfer onto
hybond-XL membrane (Amersham), probed with a
32-P
labelled DNA generated by random priming and washed
to 0.2  SSC, 0.1% SDS at 658C. Separation of intact
T. brucei chromosomes was carried out on a Bio-Rad
CHEF-DRIII apparatus. For this, each agarose plug
contained  4 10
7T. brucei cells, which had been grown
in HMI-9 to a density of  2 10
6 cells ml
 1, centrifuged
as before, washed by resuspending the pelleted cells in
10ml PSG (1 PBS, 1% w/v glucose), re-centrifuged and
then resuspended in PSG at a concentration of 1.6 10
6
cells ml
 1. The cells were then warmed at 378C for 1min
and an equal volume of 1.4% Microsieve low-melt agarose
(Flowgen) in H2O added and mixed. Disposable plug
moulds (BioRad) were ﬁlled with  50ml agarose and
placed at 48C for  4h to set. The agarose plugs were then
removed from the moulds, incubated in NDS buﬀer
(0.5M EDTA, 1mM Tris base and 34.1mM lauroyl
sarcosine) pH 9.0 containing 1mg.ml
 1 proteinase K at
508C for  24h, transferred into NDS buﬀer pH 8.0
containing 1mg.ml
 1 proteinase K at 508C for  24h, and
ﬁnally transferred into NDS buﬀer pH 8.0 for storage at
48C. For electrophoresis, the plugs were washed four times
at room temperature in 1ml of 1  TB(0.1)E (0.089M
Tris-borate pH 8.0,).2mM EDTA) for 1h each, then
placed in the wells of a 1.2% agarose (Seakem LE,
BioWhittaker Molecular Applications) gel. The gel was
electrophoresed at 158C at 2.5V.cm
 1 for 144h with a
1400–700s switch time and visualized by staining with
0.5mg.ml
 1 ethidium bromide and UV illumination.
Sequences of the integrated DNA constructs were
determined by performing PCR ampliﬁcations using
oligonucleotide primers corresponding to the ﬁrst and
last 20nt of the HYG ORF and Taq DNA polymerase
(ABgene). The resulting PCR products were puriﬁed and
sequenced using oligonucleotides primers that read
upstream and downstream from the bleomycin resistance
cassette common to each construct.
RESULTS
Assaying T. bruceihomologous recombination by targeted
genereplacement
Previously, we described an assay to examine homologous
recombination eﬃciency in T. brucei (35); this is summa-
rized in Figure 1A. The assay relies upon a hygromycin
phosphotransferase ORF (HYG) integrated into the
tubulin array (47) on chromosome 1, providing a unique
site for recombination. Recombination eﬃciency is
determined by measuring the transformation rate of
linear constructs containing a bleomycin resistance
cassette (BLE) ﬂanked by sequences derived from HYG.
The advantage of this approach is that a single, deﬁned
site for recombination is analysed from which a number of
parameters can be varied (see below). In addition, using a
foreign sequence as a target reduces the potential for
recombination into related sequences elsewhere in the
genome, an issue that has inﬂuenced other studies where
endogenous T. brucei sequences are used both as a
genomic target and recombination substrate; e.g.
(40,46,48). Although transformation of any organism is
likely to be aﬀected by a number of factors, including
DNA concentration, transformation conditions and
growth of the cells, this appears to be a reliable measure
of recombination in T. brucei. The same assay has
demonstrated the importance of T. brucei MMR in
controlling homologous recombination between sequences
containing base mismatches (35)(see below). Moreover,
related transformation assays have quantiﬁed the role in
recombination of a number of T. brucei genes, including
RAD51 (28,46), MRE11 (48), DMC1 (49) and two
RAD51-related genes (RAD51-3 and RAD51-5) (29), and
have looked at the importance of target copy number (40).
Most likely, this approach succeeds because virtually all
stable transformants in T. brucei integrate linear DNA by
homologous recombination, rather than by end-joining
processes, and the formation of extra-chromosomal
episomes following such transformation has not been
described (50).
Using this assay we have shown previously that
T. brucei homologous recombination, acting on substrates
with targeting ﬂanks of 450bp, becomes increasingly less
eﬃcient as the level of sequence homology between the
ﬂanks and the genomic HYG target decreases (35). One
percent of sequence divergence resulted in a 2.8-fold
reduction in transformation eﬃciency, and 11% diver-
gence caused a near 100-fold reduction. By mutating the
T. brucei gene encoding MSH2, we showed that transfor-
mation eﬃciencies of substrates with 2–11% sequence
divergence increased by around 9-fold, indicating that
MMR is an important regulator of homologous recombi-
nation. Nevertheless, it is not the sole factor that
determines the success or failure of recombination on
such substrates, as the same decline in transformation
eﬃciency with increasing divergence was seen in both
Nucleic Acids Research, 2007, Vol. 35, No. 10 3481MSH2-/- and wild-type cells. In this study, we have
examined two further features of T. brucei homologous
recombination. First, we tested the relationship between
substrate length and recombination eﬃciency. Second, we
asked if MMR has the same inﬂuence on homologous
recombination between diverged substrates when the
length of homology becomes short. To do this, a series
of constructs with targeting ﬂanks varying in size from 25
to 200bp were generated (Figure 1B). These were derived
by high-ﬁdelity PCR from the previously described
constructs with 450bp ﬂanks (35) that are either perfectly
homologous to the genomic HYG sequence (0% sequence
divergence), or that contain base mismatches resulting in
either 5 or 11% divergence. Linear DNA was prepared by
PCR ampliﬁcation, rather than by restriction digestion,
because non-homologous overhangs at the DNA ends,
while insigniﬁcant for an integration ﬂank of 450bp, could
have larger eﬀects on recombination eﬃciencies mediated
by the shorter substrates. The transformation eﬃciency of
each construct was determined in msh2 / , MSH2þ/ 
and wild-type bloodstream stage T. brucei strains (35,41).
The results of this analysis are graphed in Figures 2 and 3,
and summarized in Tables 1 and 2.
T. bruceihomologous recombination displays astrict
dependenceon substrate length
Comparing the transformation eﬃciencies of constructs
with 100% sequence identity with the genomic HYG
target indicates that T. brucei homologous recombination
eﬃciency is dependent on substrate length. Over the range
200–50bp, a linear relationship was found between
transformation eﬃciency and substrate length (Figure 2).
The average transformation rate for the 50bp construct in
the MMR-proﬁcient cells (MMRþ; either wild type or
MSH2 þ/ ) was 0.80   0.45 transformants   10
 6 cells,
corresponding to a near 13-fold reduction in eﬃciency
compared with the 200bp construct (10.16   0.38 10
 6).
Beyond this range the linear relationship broke down. It
appears that around 50bp of sequence homology repre-
sents a lower threshold for T. brucei recombination, at
which point the reaction becomes extremely ineﬃcient: the
25-bp substrate displayed an average transformation
rate in MMRþ cells (0.02   0.06 10
 6) that was
around 500-fold lower than the 200bp substrate and
40-fold lower than the 50bp substrate. It is notable,
however, that transformants can be generated with 25bp
ﬂanks, and that these can integrate by homologous
recombination (Figure 4)(46). By comparing the transfor-
mation rate of the 200bp construct with the restriction-
digested plasmid containing 450bp of homologous ﬂank
used previously (35), it appears that the rate of transfor-
mation reaches a plateau around 200bp. This may
indicate that T. brucei recombination becomes no more
eﬃcient with substrates longer than 200bp, though it is
also possible that this is not a reﬂection of recombination
but represents the maximum transformation eﬃciency
achievable in bloodstream stage cells under these in vitro
conditions.
Mutation of MSH2, resulting in T. brucei cells
with impaired MMR (MMR ), had no discernible
eﬀect on recombination for any of 100% homologous
constructs in the range 25–200bp. This contrasts with
the 450bp parental construct, which showed a small
(1.6-fold; Figure 3, Table 1) but signiﬁcant increase in
recombination in msh2 /  cells relative to MMRþ cells
(35). Elevation of recombination between similar-sized
(350bp), sequence-matched substrates is seen also in
S. cerevisiae MMR mutants (51,52). The basis for this
is unknown, but its absence on shorter substrates
may indicate that MMR acts to suppress recombination
on sequence-matched substrates only when they are
of a signiﬁcant length, perhaps because they are
more prone to secondary structure during strand
exchange.
RecombinationofshortsubstratesinT.bruceicanoccurbyan
MMR-independent pathway
On 450bp substrates containing base mismatches relative
to the genomic HYG sequence, increasing levels of
sequence divergence had an exponentially deleterious
eﬀect on T. brucei homologous recombination (35).
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Figure 2. Transformation rate relative to substrate length and sequence
homology. Plotted values represent the mean transformation eﬃciency
for wild type, MSH2 heterozygous (þ/ )o rMSH2 homozygous ( / )
bloodstream stage T. brucei cells derived from at least three separate
experiments; the error bars show standard error and the dotted lines
depict the lowest detectable transformation rate in this assay. The
upper graph depicts the relationship between transformation and
substrate length with constructs that are 100% sequence matched
(0% divergence), while the middle and lower graphs show the eﬀect of
increasing substrate divergence to 5% (95% sequence homology) and
11% (89% homology), respectively.
3482 Nucleic Acids Research, 2007, Vol. 35, No. 10Furthermore, mutation of MSH2 resulted in a mean
9-fold elevation in the rate of transformation when
sequence divergence was 42% (Figure 3, Table 1). The
transformation measurements in this study show that
base mismatches and MMR regulation do not have a
uniform eﬀect on recombination over the range of
substrate length analysed. This can be seen by examining
the data in two ways. First, we examined the eﬀect
that mutating MSH2 had on recombination of the 5 and
11% diverged substrates (Figures 2 and 3, Table 1).
On the 5% diverged substrates, a statistically signiﬁcant
elevation in transformation eﬃciency in the MMR  cells
relative to the MMRþ cells was observed only on the
450 and 200bp substrates. In contrast, though the
5% diverged substrates smaller than 200bp appeared
to show a trend towards a slight increase in transfor-
mation in MMR  cells, this was not signiﬁcant.
Comparing the average transformation rates of
these constructs conﬁrms this (Table 1): the 450 and
200bp substrates displayed 9.3- and 5.3-fold increases,
respectively, in transformation rate in the MMR 
cells relative to MMRþ cells, whereas averaging the
data from all substrates below 200bp revealed a
mean 3.4-fold increase (range 1.3–6.7). On the 11%
diverged substrates, impairment of MMR caused no
signiﬁcant elevation in transformation eﬃciency relative
to the MMRþ cells on any substrate other than the
longest (450bp).
The second way we examined these data was
to compare the transformation rates of the 5 and
11% diverged constructs, in both the MMRþ and
MMR  cells, relative to the perfectly matched substrates.
This is quantiﬁed in Table 2 by determining the extent of
the reduction in average transformation rate of each 5 or
11% diverged substrate relative to the sequence-matched
substrate of cognate length. In both the MMRþ and
MMR  cells, at virtually all substrate lengths, increasing
sequence divergence caused a progressively more severe
impairment in transformation rate. However, in MMRþ
cells this eﬀect was more pronounced on 450 and 200bp
substrates than on any substrate shorter than 200bp.
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Figure 3. A comparison of transformation eﬃciency in mismatch
repair-proﬁcient and -deﬁcient T. brucei cells. The values in the bar
charts depict the average transformation rates of constructs with
decreasing lengths of targeting ﬂanks; error bars show standard
error. In each case, white bars show the transformation rate of
MMR-proﬁcient cells (MMRþ; wild type and MSH2þ/ ) and grey
bars depict MMR-deﬁcient cells (MMR ; msh2 / ). The top graph
shows transformation rates of constructs with 100% sequence
homology (0% sequence divergence) with the genomic HYG target,
while the middle graph shows constructs that have 95% homology
(5% divergence) and the lower graph shows constructs with 89%
homology (11% divergence). Asterisks indicate a statistically
signiﬁcant diﬀerence between the transformation rate in the
MMRþ and MMR  cells (P50.05; two sample t-test).
Table 1. The values shown are the fold ‘increase’ in the average
transformation rate in msh2 /  cells relative to MMR-proﬁcient cells
(wild type and MSH2þ/ ) measured using constructs with diﬀerent
lengths of targeting ﬂanks, and with 0, 5 or 11% sequence divergence
(100, 95 and 89 homology, respectively) from the genomic HYG target;
ND indicates not determined
Length (bp) 100% 95% 89%
450 1.57 9.29 9.4
200 0.97 5.3 4.4
175 0.81 1.73 1.68
150 1.06 5.22 0.64
125 0.78 1.63 ND
100 0.78 1.33 3.5
75 0.62 6.69 0.1
50 1.77 1.83 3
25 3.5 2.5 1.5
Table 2. The values show the fold ‘decrease’ in transformation rate of
5 and 11% diverged substrates relative to sequence-matched
(0% divergence) substrates; data are shown from MMR-proﬁcient
(MMRþ; wild type and MSH2þ/ ) and MMR-deﬁcient (MMR ;
msh2 / ) cells over a range of diﬀerent substrate lengths
Length (bp) MMRþ MMR 
5% 11% 5% 11%
450 33.4 93.4 5.6 15.6
200 15.4 203.2 2.8 66.8
175 7.1 29.6 3.3 14.2
150 14.6 16.2 3 26.8
125 3.9 ND 1.9 ND
100 2.8 38.9 1.6 8.6
75 13.8 8.5 1.3 55.5
50 6.7 40 6.5 23.7
25 1 1 1.4 2.3
Nucleic Acids Research, 2007, Vol. 35, No. 10 3483In contrast, in MMR  cells the extent to which sequence
divergence impaired transformation was more uniform
across all lengths. The average level of reduction in
transformation of 5% diverged substrates smaller than
200bp in MMRþ cells was 8.1-fold, compared with a
3-fold reduction of all substrates in MMR  cells. For
11% diverged substrates, the reduction in transformation
rate for substrates smaller than 200bp was the same as all
substrates in MMR  cells (26.6- and 26.7-fold, respec-
tively). Taken together, these data argue that T. brucei
MMR has an important role in regulating recombination
between diverged sequences when the substrates are long
(around 200bp or longer), but MMR has a less signiﬁcant
role on shorter substrates. Higher levels of sequence
divergence presumably exacerbate this because the
lengths of uninterrupted homology stretches in such
substrates are reduced.
Most T. brucei integrative recombination occurs by
homologous recombination
An important consideration in the above analysis, and in
previous work using the same assay (35), is whether or not
the experimental approach measures T. brucei homolo-
gous recombination on all substrates. For instance, it may
be that MMR has less inﬂuence on recombination of
short substrates because primarily non-homologous
pathways of recombination act upon such sequences.
Indeed, we have shown that some DNA integration in T.
brucei can occur by a pathway mediated by sequence
microhomology (46). Homologous recombination of the
constructs into the genomic HYG locus should lead to loss
of hygromycin resistance (Hyg
S) due to disruption of the
gene by BLE. We therefore tested the antibiotic resistances
of a large number of transformants (Figure 4), revealing
that a signiﬁcant proportion of transformants in wild
type, MSH2þ/  (data not shown) and msh2 /  cells
retained hygromycin resistance (Hyg
R). There was, how-
ever, no clear relationship between the retention of
functional HYG and either substrate size or level of
sequence homology. Although the numbers of Hyg
R
transformants appeared to increase in wild-type cells as
substrate length decreased from 200 to 50bp at 0%
divergence, the same trend was not apparent in msh2 / 
cells (Figure 4) or in MSH2þ/  cells (data not shown).
Determining the average level at which Hyg
R cells
arose, using the accumulated data for all substrate
lengths, showed that this is not inﬂuenced by the extent
of divergence: 15.1, 9.2 and 16.7 of transformants
were Hyg
R for the 0, 5 or 11% diverged substrates in
wild-type cells, respectively, compared with 28, 20.5 and
26.9% of transformants in msh2 /  cells. These latter
data do, however, indicate that Hyg
R transformants
appeared to be slightly more prevalent (around 2-fold)
when MSH2 was mutated, perhaps indicating that
0% 5% 11%
0
20
40
60
80
100
21 8 78 87 103 0 9 27 18 2 0 0 14 6 5
0
20
40
60
80
100
25 50 100 150 200
M
S
H
2
w
t
P
e
r
c
e
n
t
a
g
e
 
o
f
 
c
l
o
n
e
s
7 68 65 101 106 3 18 51 65 85
25 50 100 150 200 25 50 100 150 200
HYGR
HYGS
M
S
H
2
−
/
−
12894
Substrate length 
(bp)
Figure 4. Antibiotic resistance patterns of transformants generated in the recombination assay. The bar charts show the proportion of hygromycin
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R; black) and sensitive (Hyg
S; white) transformant clones recovered in wild type (wt) or MSH2 homozygous ( / ) mutant T. brucei
bloodstream stage cells following the transformation of constructs of varying substrate length and 0, 5 or 11% divergence from the genomic HYG
sequence. Values above the charts indicate the number of transformants analysed.
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formation.
To examine the recombination pathway(s) that gives
rise to Hyg
R transformants, a number of clones were
examined by Southern analysis. The large majority of
Hyg
R transformants had integrated the constructs by
homologous recombination. In msh2 /  cells, 20 of the
24 clones examined had maps indicative of HYG disrup-
tion by homologous integration of BLE (Figure 5). Re-
probing the blot with a portion of the HYG ORF revealed
that the antibiotic marker had been duplicated (based on
the equivalent signal intensity of the two HYG bands) in
these clones, explaining why they retained resistance to
hygromycin. The four other Hyg
R msh2 /  transfor-
mants had not integrated BLE into the tubulin HYG
target, but instead into unmapped genomic locations, and
the HYG marker was unaltered. A broadly similar pattern
of BLE integration was seen for Hyg
R transformants in
wild-type cells (data not shown). Here, 24 clones were
examined, and 23 had disrupted HYG by homologous
recombination but retained a functional copy, whilst 1 had
integrated BLE into an aberrant genomic location. The
greater number of aberrant integrations in the msh2 / 
cells may indicate that this minor recombination pathway
gains prominence in the absence of MMR. Furthermore,
most aberrant integrations were seen using relatively short
or diverged substrates: Three of the msh2 /  clones had
arisen from 11% diverged substrates of 100bp (Figure 5,
lanes 12, 13 and 23) and one had arisen from a 50bp,
100% homologous substrate (Figure 5, lane 3); the wild
type aberrant integrant arose from a 100bp, 100%
homologous substrate.
The above data suggest that two putatively distinct
pathways operate in the context of this T. brucei
recombination assay to generate hygromycin-resistant
transformants. A minor pathway is integration events
that do not target the tubulin locus, as directed by the
terminal targeting ﬂanks, but into other genomic loci.
Although we have not mapped these integrations, the
background rate at which they occur is very reminiscent of
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Figure 5. Genomic analysis of hygromycin-resistant transformants in msh2 /  mutants. (A) A Southern blot of genomic DNA from MSH2
homozygous mutant transformant clones digested with HindIII and probed with the bleomycin resistance gene ORF (BLE). The same blot was
then stripped and re-probed with a portion of the hygromycin-resistance gene ORF (HYG). Asterisks denote transformants in which the constructs
have integrated aberrantly. The constructs that gave rise to each transformant are in the following lanes: 1–3, 0%–50bp; 4–5, 0%–100bp; 6–7,
0%–150bp; 8–9, 0%–200bp; 10, 5%–150bp; 11, 5%–200bp; 12–13, 11%–100bp; 14, 11%–150bp; 15, 0%–100bp; 16–17, 0%–150bp; 18–19,
5%–100bp; 20–22, 5%–200bp; 23, 11%–100bp; 24, 11%–150bp. (B) A depiction of the expected restriction map of the HYG locus before
(upper diagram) and after (lower diagram) homologous integration of BLE. The positions of probe fragments and the expected size of HindIII
fragments are indicated.
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before (46). The prevalent pathway, in contrast, is a
homologous recombination reaction associated with
retention of a functional HYG gene. A number of
processes could account for this. First, it is possible that
duplication (or ampliﬁcation) of HYG occurs at a
relatively high rate in the growth of these clonal
T. brucei lines, perhaps due to recombination within the
multigenic tubulin locus. Second, larger scale changes in
chromosome copy number (for instance, trisomy arising
from replication errors) could be rather common in
T. brucei. Finally, it is possible that a form of recombina-
tion, termed break-induced replication (53), could be
commonly induced by such construct integrations, leading
to the duplication of large stretches of chromosome 1, or
even the complete chromosome. To examine this, we
characterized a selection of Hyg
S and Hyg
R transformants
from wild-type cells by pulsed ﬁeld gel electrophoresis
(Figure 6). One Hyg
R transformant (Hyg
R5), which arose
as a result of an aberrant integration, contained a novel
chromosome, 370kb in size, that contained BLE and
HYG sequence (data not shown). Such alterations in
chromosome structure have been seen previously in
microhomology-mediated reactions (46), providing
further indirect evidence as to the recombination pathway
involved in these integrations. In contrast, no diﬀerences
in karyotype were seen in the other Hyg
R transformants
(that had utilized homologous recombination; Hyg
R1-4)
when compared with the Hyg
S cells or the parental strain,
suggesting that large changes in chromosome structure are
not associated with these events. Furthermore, probing of
a Southern blot of these transformants (Supplementary
Figure 3) indicated that there was no diﬀerence in the
relative amount of chromosomes 1 and 2. Since the
tubulin array in which HYG is inserted is located on
chromosome 1, this suggests that integration of BLE did
not result in the generation of a new copy of the
chromosome. Taken together, it seems likely that Hyg
R
in some transformants is not a consequence of targeted
integration by BLE, but results from events that amplify
HYG in the tubulin locus and are a constant background
process in the HTUB cell lines.
Construct integration occurs by independent invasion ofthe
DNAends,andmismatchesarerepairedbyshort-patchrepair
To examine the mechanisms that contribute to the
recombination and processing of the constructs during
integration, we sequenced the DNA surrounding the
homologously integrated BLE marker in a number of
transformants clones generated in both wt and msh2 / 
cells using constructs with 50, 100, 150 or 200bp ﬂanks of
5 or 11% sequence divergence. We did not examine any
clones that had integrated BLE aberrantly. The results in
Figure 7 depict the pattern of residues in the transformant
DNA that are mismatched between the constructs and wt
HYG target. Most of the transformants had a trans
pattern of sequences, in which the majority of mismatched
residues corresponded to the sequence of the construct
DNA on one side of BLE and the genomic HYG target on
the other; no diﬀerence in this pattern was observed if the
transformants were Hyg
R or Hyg
S (data not shown). Only
clone 9 (from wt cells using a 100bp, 5% diverged
construct) was substantially diﬀerent, with HYG sequence
in both directions. Clone 23 (msh2 /  cells with 200bp,
5% construct) was somewhat diﬀerent also, with pre-
dominantly HYG-derived residues. Such a trans pattern is
consistent with a model for targeted gene replacement in
yeast (54) and mammals (55) involving independent strand
invasions by both arms of the construct (Figure 9). Such a
model predicts that heteroduplex DNA can form by
strand invasion of each construct end, which can result in
‘sectored’ or mixed sequence at the mismatched residue
positions following replication of the heteroduplex (see
Figure 9). However, no such mixed sequence was observed
in this study: at each position where a base mismatch
might from during strand invasion, the sequences were
clearly either construct-derived or HYG- derived. This
infers either that heteroduplex does not form or that
repair of such mismatches is normally rapid and occurs
before replication. The distribution of construct and
HYG-derived sequences was very similar in the msh2 / 
and wt transformants, indicating that if mismatch repair
occurs it can proceed independently of MSH2. In each
transformant in which construct-derived residues were
present in the transformed DNA, this was not continuous
along the length of the ﬂank, but was combined with
HYG-derived residues. Most likely, HYG-derived residues
that are distal to BLE in the ﬂanks of transformants with
an otherwise continuous tract of construct-derived
sequence (clones 6, 22, 35, 30, 24, 37, 38) result from
nucleolytic degradation of the ends of the linear molecules
following transformation and before integration. This was
most extensive in clone 30 (maximally 76bp), whereas in a
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Figure 6. Pulse ﬁeld gel electrophoretic analysis of transformants.
Intact chromosomal DNA from untransformed cells (HTUBwt), and
from 5 hygromycin resistant (Hyg
R) and 3 hygromycin sensitive (Hyg
S)
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position of a novel, 370kb molecule in the Hyg
R5 transformant.
3486 Nucleic Acids Research, 2007, Vol. 35, No. 10number of other clones mismatched residues close to the
ends of the construct molecules had been integrated (e.g.
within 15bp in clones 41 and 15, and 32bp in clones 37
and 38), arguing that such degradation need not be
substantial. In a number of other transformants, the
ﬂanks contained a discontinuous pattern of construct and
HYG-derived sequence tracts (clones 1, 15, 41, 23), and
some of the residues that were patterned in this way were
positioned in close proximity (e.g. separated by only 2 and
8 bpin clones 15 and 23, respectively). This patterning is
most simply explained by the formation of heteroduplex
DNA during homologous integration and the repair of
base mismatches prior to replication by short-patch
mismatch repair.
DISCUSSION
The primary conclusion from this work is that T. brucei
homologous recombination has substrate characteristics
that are typical of those described in other organisms.
The signiﬁcance of this lies in our understanding of the
relationship between homologous recombination and the
critical immune evasion process of antigenic variation,
which involves switches in VSG expression. Genetic
evidence points to antigenic variation being closely
linked to homologous recombination, despite the fact
that VSG gene switching occurs at high rates (30,31), often
acts upon rather short, diverged sequences (22,33,34) and
frequently recombines VSGs on diﬀerent chromosomes to
the VSG ES (14,34), characteristics that are unusual for
stochastic homologous recombination. We have shown
previously that the eﬃciency of T. brucei homologous
recombination is dependent on substrate homology, which
is at least partially controlled by the T. brucei MMR
machinery (35). We now show here that recombination
eﬃciency is also dependent on substrate length, at least
over the range 25–200bp. This indicates that speciﬁc
features of VSG switching have not arisen through
modiﬁcations of the T. brucei recombination machinery
in these two key features. This conclusion is perhaps not
surprising, as the primary function of homologous
recombination is to repair DNA damage (3) and ensure
the completion of replication (7), and therefore funda-
mental reaction changes could have far-reaching eﬀects on
genome integrity. Any speciﬁcity of homologous recom-
bination during VSG switching must therefore involve
elements or factors that have not yet been uncovered and
may be unique to T. brucei. Similar conclusions have been
reached regarding antigenic variation in pathogenic
Neisseria sp., where convergent evolution has produced
a related immune evasion reaction that is also closely
linked to homologous recombination (13).
The relationship we describe in T. brucei between
substrate length and recombination rate (measured
indirectly as transformation rate) appears to be conserved
throughout evolution. In E. coli, three studies have
recorded reductions in recombination eﬃciency over the
range 74–20bp (56), 405–27bp (57) and 200–25bp (58).
In eukaryotes, S. cerevisiae recombination rate appears to
decrease over 960-80bp (59) or 2kb–26bp (60), and in
mammalian cells a similar relationship has been recorded
between an upper length of around 6.8 (61) to 10kb (62)
and a lower length between  160 (63) and 330bp (64).
Variations in whether the relationship between
Wildtype
1.   50bp   5%
6.   100bp 5%
9.   100bp 5%
15. 150bp 11%
35.  100bp 5%
22.  150bp 5%
30.  150bp 5%
41.  150bp 11%
23.  200bp 5%
24.  200bp 5%
37.  200bp 5%
38.  200bp 5%
msh2−/−
Figure 7. Mismatched base patterns in the DNA of integrated constructs. Circles denote the positions of bases that are mismatched between
transformation constructs and the genomic HYG gene that is targeted by homologous recombination; ﬁlled circles denote that the sequence of a base
matches the construct sequence, while open circles denote genomic HYG base sequence. The targeting ﬂanks of the constructs are shown as lines, and
the grey box indicates the central BLE resistance marker used for selection of transformants. Clone numbers for each DNA sequence are shown to
the right, as well as the length of the ﬂanks, the extent of sequence divergence relative to HYG, and whether the transformants were generated in wild
type or msh2 /  T. brucei cells.
Nucleic Acids Research, 2007, Vol. 35, No. 10 3487recombination rate and substrate length is linear or
exponential and in the range of substrate sizes involved,
both within and between organisms, presumably reﬂect
diﬀerences in the assays used, meaning that it is diﬃcult to
compare the absolute sequence requirements of the
recombination machineries between each organism.
Nevertheless, a sharp drop in recombination eﬃciency
below a lower threshold, referred to as the minimal
eﬃcient processing segment (MEPS)(57), has been
described in E. coli (57), S. cerevisiae (59) and mammalian
cells (63). We observed the same phenomenon in T. brucei,
reinforcing our view that the recombination machinery in
the parasite operates in the same manner. Despite this
broad evolutionary conservation, previous reports have
suggested that T. brucei recombination eﬃciency is not
aﬀected by substrate length over the range 50–400bp
(40,65), which is diﬃcult to reconcile with the ﬁndings
detailed here. One of these reports compared constructs
that target distinct genomic locations (40), and it may be
that diﬀerences in target accessibility (for instance,
through chromatin structure or transcription level) aﬀect
recombination eﬃciency and confounded the analysis.
Another explanation may be revealed by linear regression
analysis (Figure 8), which suggests that the MEPS for T.
brucei on sequence-matched substrates is around 31bp,
shorter than the estimates in either S. cerevisiae or
mammals ( 250bp) (59), and closer to E. coli (around
25bp). Intriguingly, transformation data from
Leishmania, a related kinetoplastid parasite, failed to
recover any integrants when DNA constructs with less
than around 220bp of targeting ﬂank were used (66).
Though this dichotomy with T. brucei may reﬂect the
limitations of transformation in the two parasites rather
than recombination, linear regression analysis of the
(albeit limited) data set from Papadopoulou and Dumas
(1997) is consistent with a MEPS of 190bp in Leishmania
(Supplementary Figure 2), closer to the size predicted in
the two other eukaryotes. Perhaps, therefore, T. brucei has
evolved to allow homologous recombination to operate,
with reduced eﬃciency, on shorter substrates. More
analysis will be needed to examine this, but it could be
the result of diﬀerences in the activity of RAD51,
diﬀerences in the factors that mediate RAD51 function,
or a more active short-sequence recombination pathway.
The second conclusion from this work is that T. brucei
contains an MMR-independent, or at least an MSH2-
independent, pathway for homologous recombination
that has not previously been described. On 5% diverged
substrates in the size range 50–175bp, and on 11%
diverged substrates in the range 50–200bp, this pathway
appears to assume considerable signiﬁcance, but is
subordinate to MMR-dependent recombination on
longer substrates (450bp) containing these levels of
sequence divergence. This argues that the reaction
assumes a greater role during T. brucei homologous
recombination as substrate length decreases.
Characterization of transformants by antibiotic resistance
and Southern analysis suggests that the considerable
majority of T. brucei recombination, at all sequence
lengths, occurs by homology, suggesting that the
MMR-independent reaction is capable of precise
integration. We have described a DNA repair process in
T.bruceibasedonthejoiningofDNAmoleculesusingvery
short stretches of homology, typically 5–15bp in length
(46), and similar reactions have been described in other
eukaryotes (67,68) and potentially in bacteria (69–71).
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Figure 8. Linear regression analysis comparing the relationship between
transformation rate and substrate length in T. brucei. Transformation
rate was plotted for the combined wild type and MSH2þ/  (MMR
proﬁcient; MMRþ) data for the sequence-matched substrates (0%
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Mismatch Short patch No repair
Replication
Figure 9. Gene targeting by two-end invasion. Grey boxes denote the
BLE selectable marker. Lines indicate the ﬂanks of the transformation
construct or HYG target, within which black circles denote bases in the
targeting construct that are mismatched with bases in HYG, which are
shown in equivalent positions but as white circles. The boxed diagram
denotes the route of targeted integration. Below is a model for
integration showing how the 30 single-strand ends of the construct
invade HYG (dotted lines denote 50-30 nucleolytic degradation), and the
result of resolution of the strand exchange intermediate. The pattern of
mismatched bases in the integrated DNA is then shown following
replication of the chromosome to yield two daughters, distinguishing
the outcomes if no DNA repair of the mismatches occurs (left), or if
mismatch repair precedes replication and occurs in favour of the lower
DNA strand (middle), or if repair occurs by short-patch repair with an
incomplete bias towards the lower strand (right).
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T. brucei MMR-independent recombination, for two
reasons. First, examination of the transformation rates of
the 5% diverged substrates 175bp or smaller, and of the
11% diverged substrates 200bp or smaller, suggests that
transformation by the MMR-independent pathway can be
as eﬃcient as 1 10
 6 transformants  cells
 1, since these
are conditions in which it is likely that most integrations
occur by this route. This is considerably higher than the
maximum transformation rate (0.1 x 10
 6) described for
the microhomology reaction in RAD51 wild-type T. brucei
(46). Second, in most reactions where we have demon-
strated that microhomology guides construct integration,
this is associated with visible karyotype changes (46),
suggesting that the reaction may be an end-joining process
that exploits random DNA breaks, leading to genomic
rearrangements. In contrast, such rearrangements are very
rare in the extensive numbers of transformation events we
have characterized here, including the conditions in which
MMR-independent recombination would be expected to
be prominent.
The presence of a putative MMR-independent recom-
bination reaction in T. brucei is reminiscent of pathways
described in S. cerevisiae, at least superﬁcially. Although
Rad51 is a central factor in DNA strand exchange during
homologous recombination, some reactions in S. cerevi-
siae can occur in its absence; reviewed in (72). Rad52
appears to be essential for nearly all recombination in
yeast, suggesting it contributes to both Rad51-dependent
and -independent recombination. A relative of Rad52,
termed Rad59, was identiﬁed in a search for factors
required for recombination in S. cerevisiae rad51 mutants
(73), and the suggestion that both proteins contribute to
Rad51-independent reactions is supported by ﬁndings that
each can catalyse strand annealing (74). Rad59-dependent
recombination requires less sequence homology than the
Rad51-dependent reaction (53), and displays a lower
degree of regulation by Msh2, and hence MMR, during
recombination of diverged DNA sequences (75). A
prediction, therefore, is that that the MMR-independent
recombination we see in T. brucei is RAD51-independent.
We have not tested this directly, but some data appear
consistent with this hypothesis. Linear regression analysis
of the data presented here on substrate length and T.
brucei transformation rate is best accounted for by two
lines of best ﬁt, consistent with two pathways operating
(Figure 8). Above around  150bp a pathway predomi-
nates that has a MEPS of  100bp, whereas below
 150bp a distinct pathway with a MEPS of  31bp.
Interestingly, the longer MEPS is consistent with previous
estimates of RAD51-dependent T. brucei recombination
acting on long (450bp) substrates (35). Despite the
considerable ineﬃciency of homologous recombination
on substrates shorter than the MEPS, the assay we have
used here shows that such recombination can occur, as has
been found in yeast (76), mammalian cells (64) and E. coli
(where recombination of 25bp substrates is predomi-
nantly RecA-independent)(58). Indeed, 80% of the
transformants that arose from the constructs with only
25bp of homology were Hyg
S (Figure 3), demonstrating
that they had integrated by homologous recombination.
In S. cerevisiae, recombination of short substrates around
29–40bp is not only Rad51-independent, but mutation of
Rad51 increases the reaction eﬃciency (53). In T. brucei,
transformation of constructs with very similar-sized
regions of homology (24bp) occurs at essentially the
same frequency in rad51 /  and wild-type cells, suggest-
ing the action of a RAD51-independent pathway (46).
Despite these similarities, it is unclear what factors would
catalyse RAD51-independent homologous recombination
in T. brucei. Rad52 and Rad59 belong to a superfamily
that is not conserved universally (77), and homologues of
both proteins are either absent from the T. brucei genome
(78), or are suﬃciently diverged in sequence to have
escaped detection. It is therefore possible that T. brucei
contains recombination factors, thus far unidentiﬁed and
distinct from RAD51, that can perform the functions
equivalent to the pathway in which Rad59 and Rad52 act
in S. cerevisiae.
Identiﬁcation of an MMR-independent pathway of
homologous recombination could be important in under-
standing antigenic variation and genetic variability in
T. brucei. Although antigenic variation is impaired in
RAD51 mutants, VSG gene conversion reactions can still
be catalysed (28). It is plausible that the MMR-
independent pathway, if it is RAD51-independent, could
explain these residual VSG switching events. There is also
no evidence that VSG switching is inﬂuenced by MMR
(35), which appears to be at odds with the requirement for
RAD51, since this pathway should be suppressed by
MMR. However, although assays for recombination in
yeast rad51 mutants reveal functions for Rad59 in deﬁned
recombination pathways, it is very likely that in wild-type
cells Rad51, Rad59 and Rad52 actually act together
(53,75). Trypanosoma brucei VSG switching may therefore
occur by a speciﬁc recombination pathway that requires
RAD51, but is directed towards an MMR-independent
route by unidentiﬁed factors that act like Rad59. Indeed,
this could explain the ability of VSG switching to use
rather short and dissimilar DNA sequences as substrates,
such as the 70bp repeats upstream of VSG genes.
Furthermore, although nothing is known about the
genetic requirements of segmental gene conversion involv-
ing the VSG pseudogenes, it is clear that VSG genes share
very little primary sequence homology (525% identity
between encoded amino acids in 495% of the VSG
repertoire; L.Marcello and J.D.Barry, personal commu-
nication). It is therefore possible that an MMR-indepen-
dent reaction, active on short stretches of homology,
would be involved. It is important to note that to date we
have only assayed T. brucei homologous recombination at
one interstitial site. Although some work has suggested
that T. brucei recombination occurs at equivalent eﬃcien-
cies in diﬀerent genomic locations (40), it is important to
examine this systematically and to assess the pathways
used. For instance, it is clear in other organisms that other
factors, such as transcription (79), can inﬂuence recombi-
nation, and some work has suggested that diﬀerent
pathways of recombination are active in interstitial
relative to subtelomeric environments (80). Moreover,
recombination can contribute to the maintenance of
Nucleic Acids Research, 2007, Vol. 35, No. 10 3489telomeres (9), and the pathway(s) that acts in this regard in
T. brucei is unknown (81).
In any model in which MMR triggers the rejection of
recombination between mismatched DNA substrates,
heteroduplex DNA must form during the strand exchange
step. In MMRþ cells in which recombinants escape
rejection, such heteroduplex is likely to be repaired,
whereas it should be visible in MMR  cells. An MMR-
independent pathway may or may not generate hetero-
duplex, since it could avoid MMR surveillance by using
short, perfectly matched sequences or because the strand
exchange mechanism between mismatched molecules
avoids triggering MMR. We cannot readily distinguish
these possibilities through sequencing the integrated DNA
in these experiments. In no transformant, even in MMR 
cells, did we ﬁnd evidence for the DNA having a mixture
of construct and genomic HYG sequence at the mis-
matched residues, which would arise if heteroduplex
formed and was not repaired prior to replication, as
illustrated in Figure 9. Instead, we saw a predominant
trans pattern of construct sequence to one side of the
integrated marker and HYG sequence on the other. This is
most readily explained by independent strand invasion
and annealing between a 30 single strand on each side of
the BLE marker and the genomic HYG target, suggesting
that the mechanism of homologous recombination during
targeted gene replacement in T. brucei is equivalent to that
in yeast and mammals (54,55). The one exception we
found, where all the sequence is HYG-derived, occurred in
wild-type cells (clone 9, Figure 7). This could result from
MMR of the heteroduplex in favour of the recipient, HYG
DNA. Alternatively, it could indicate that construct
integration occasionally occurs by annealing of a single
strand encompassing both arms of the construct, followed
by mismatch repair; such a mechanism has been seen in
yeast (82), though appears to be rare (54). One distinction
between targeted gene replacement in T. brucei and S.
cerevisiae is revealed here: mutation of MSH2 in T. brucei
either increased the frequency of transformation or had no
eﬀect, depending on substrate length, whereas the same
mutation in S. cerevisiae results in reduced integration
rates (83). This may indicate that the parasite MSH2
protein does not promote recombination in the ways it has
been found to do elsewhere (84).
The lack of clear evidence for heteroduplex DNA is
perplexing. In wild-type cells, the lack of mixed sequence
at mismatched residues could be explained by MMR that
acts following construct integration and is directed
towards one or other DNA strand by, for instance, the
direction of replication (Figure 9). However, the same
pattern was seen in the msh2 /  transformants. In
addition, we did not see any striking diﬀerence in this
pattern as construct length changes, which could arise
through a shift in the substrate requirements of the
recombination pathways being used. It is conceivable that
in all these conditions most strand exchange is limited to
perfectly matched sequences between the construct and
HYG target, and crossovers then occur on these inter-
mediates to incorporate both strands of the construct
DNA. However, a number of ﬁndings argue against this.
First, we did not observe construct sequence on both sides
of BLE, and it is not clear how crossover integration could
be directional in this way. Second, it is diﬃcult to explain
by this model the rather common appearance of trans-
formants in which tracts of construct sequence were
interrupted by patches of HYG sequence in the ‘left’ arms
(clones 1, 15, 41, 23; Figure 7). Finally, the length of
homology that mediates strand pairing would have to
have been very short in some cases (e.g. 15bp in clone 41,
and 12bp in clones 6, 35 and 30; Figure 7). For these
reasons, we suggest that heteroduplex does form during
homologous integration and that it is repaired by short-
patch MMR. This would explain the predominant pattern
of sequence we see in the integrated DNA (Figure 9).
Furthermore, it most readily explains transformants in
which construct-derived and HYG-derived residues were
found in close proximity. Such a situation is consistent
with repair of two putative mismatches in diﬀerent
directions (in favour of the invading and recipient
strands), which is distinct from long-patch MMR, where
a mismatch triggers excision of extensive regions of DNA
to allow repair (43). However, given that the trans pattern
of sequence in the transformants was predominantly with
construct sequence to the ‘left’ of BLE and HYG sequence
to the ‘right’, and that many tracts were continuous
stretches of either construct or HYG residues, it seems
likely that some feature(s) biases the direction of short-
patch repair. The nicks that are present during strand
invasion cannot explain this, as repair would then be in
the same direction for each end of the construct.
Replication or transcription seems like a reasonable
alternative, though this cannot be absolute, since we see
discontinuous tracts in a number of transformants, and
one clone has reversed the predominant pattern (clone 23;
Figure 7). Short-patch MMR has not been described in T.
brucei, but has been found in other organisms (including
during recombination), though the molecular machinery is
still being described (85,86). A consequence of the lack of
identiﬁable heteroduplex DNA in this study is that we
cannot determine how extensive the lengths of strand
exchange intermediates are in these experiments, nor
whether this diﬀers in wild-type and msh2 /  cells, as has
been reported in yeast (87,88). In addition, this approach
does not allow us to test our hypothesis that the putative
MMR-independent pathway we propose utilizes shorter
substrates. However, given the existence of mixed tracts of
construct and HYG sequence at all substrate lengths, it is
likely that heteroduplex is formed in all conditions.
A footnote in this study, which was not appreciated in
our previous analyses (35), is that we ﬁnd signiﬁcant levels
of duplication of the HYG locus in this assay. The
available evidence suggests that this is due to the
generation of additional copies of HYG in the tubulin
array during growth of the clonal HTUB T. brucei cell
lines, rather than being a consequence of the targeted gene
replacement. This ‘spread’ of a resistance marker in
tubulin has been described previously (89), and shown to
be due to unequal sister chromatid exchange. At least in
our experiments this appears to be rather frequent.
Though this may be a result of the antibiotic exerting a
selective pressure for increased gene product, it is notable
that high frequencies of allelic gene conversion have been
3490 Nucleic Acids Research, 2007, Vol. 35, No. 10described in T. brucei (90) and that considerable variation
in repetitive sequences has been described between
T. brucei strains (91). Our data also hint that impairment
in MMR may enhance HYG ampliﬁcation, perhaps
because MMR-mediated suppression of recombination
between divergent sequences is alleviated, leading to
greater rearrangements in the T. brucei genome.
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